drugset
drugset / Trial / NCT01536353

Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301

NCT01536353 ↗

Phase 1 Completed 30 enrolled Ahn-Gook Pharmaceuticals Co.,Ltd Asan Medical Center · collab
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the bioavailability and safety of AGSAV301 tablet in healthy male volunteers.

Timeline

Start
2012-01
Primary completion
2012-04
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject AGSAV301 Unknown — —
Comparator Exforge Unknown — —

Indications

hypertensive disorder